‘Concerning’: Low levels of contraception alongside GLP-1 use

Off-label use of GLP-1s among women of reproductive age has skyrocketed since 2020, with researchers concerned about its potential impact on unintended pregnancies Community pharmacists have an opportunity to counsel women of childbearing age using GLP-1 receptor agonists about appropriate contraceptive methods, in light of findings about low contraception coverage in this group, say researchers